GSK calls for research proposals into non-communicable diseases (NCDs) in Kenya and across Sub-Saharan Africa

The is part of a series of investments GSK is making across Sub-Saharan Africa. The launched in 2014, aims to work in partnership with African researchers and academic groups to conduct research into NCDs such as cancer, diabetes, cardiovascular diseaseand chronic respiratory diseases.
NCDs were estimated to account for over one quarter (27%) of total deaths in Kenya in 2014, and across the country the probability of dying at a young age (between age 30 and 70 years) from an NCD is 18%. NCDs cause over half of all reported adult deaths in some African countries, suggesting that NCDs could become a leading cause of health issues, disability and premature death.
The third call for research proposals to address these growing challenges is open from 7November 2016 until 12January 2017 and successful applicants will be awarded £100,000 for up to two years, along with scientific support from GSK.
It is hoped that the vital research conducted by scientists across the continent will improve the understanding of NCDs, and inform best practice prevention and treatment strategies.
said “Whilst huge progress has been made in recent years to understand and combat infectious diseases, more work needs to be done to tackle the growing health concern presented by NCDs in Kenya and across Sub-Saharan Africa. When an issue is better understood it can be more effectively tackled. By collaborating with our research network across Africa through the , Kenyan scientists can work to vastly improve our understanding ofNCDs in Kenya and beyond.”
, said: